Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 7, 2015; 21(9): 2777-2785
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2777
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2777
Figure 2 Comparison of overall survival between the expanded activated autologous lymphocyte and control groups.
EAAL: Expanded activated autologous lymphocyte.
- Citation: Zhang GQ, Zhao H, Wu JY, Li JY, Yan X, Wang G, Wu LL, Zhang XG, Shao Y, Wang Y, Jiao SC. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy. World J Gastroenterol 2015; 21(9): 2777-2785
- URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2777.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i9.2777